University of Utah, PPDS is a clinical research site located in Salt Lake City, Utah, United States 84108-1287.
Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Utah, PPDS has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: COVID-19, Mucopolysaccharidosis II, Duchenne Muscular Dystrophy.
Sponsors: Hoffmann-La Roche, Denali Therapeutics Inc., Sarepta Therapeutics, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Utah · View every site in Salt Lake City
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Utah, PPDS has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Utah, PPDS has 8 clinical trials on record, with 3 currently active. Their work covers COVID-19, Mucopolysaccharidosis II, Duchenne Muscular Dystrophy.
University of Utah, PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.